ImCell, Inc

A patented method to isolate primitive immature cell from umbilical cord blood to treat diseases caused by aging, damaged and dying cells.

  • Stage Not Set
  • Industry Biotechnology
  • Location Fremont, CA, USA
  • Currency USD

Company Summary

Research and development in stem cell therapy, ImCell has revolutionary breakthrough technology and commercially viable product to treat diseases caused by aging, damaged and dying cells. The technology and product have been proven safe and highly effective to treat any patient without immune rejection with low cost of operation, the key to open and provide vast opportunities for Regenerative Medicine to treat patients with “incurable diseases”.

Team

  • Mingqi Tang
    President

    Dr.Tang is top biological research leader in the field of stem cell therapy and inventor of CBCTM in China. Dr.Tang received Ph.D. in Cell Biology. He plays a very important role as chairman of committee in The International Sub-health association Branch Association of Anti-aging. He is chairman and CEO of Cell Biotech Engineering Ltd. Beijing, and research center in Shenyang, China.

  • Shaw P. Yen

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free